Total Payments
$2,549
2023 Payments
$79.69
Companies
22
Transactions
191
Medicare Patients
2,953
Medicare Billing
$288,426
Payment Breakdown by Category
Food & Beverage$2,520 (98.9%)
Education$28.89 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,520 | 189 | 98.9% |
| Education | $28.89 | 2 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $329.50 | 10 | $0 (2018) |
| Novo Nordisk Inc | $323.44 | 20 | $0 (2022) |
| PFIZER INC. | $303.28 | 58 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $246.90 | 15 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $233.36 | 19 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $227.64 | 15 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $140.39 | 9 | $0 (2020) |
| Amgen Inc. | $128.40 | 8 | $0 (2019) |
| ABBVIE INC. | $103.75 | 5 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $91.53 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $79.69 | 4 | GlaxoSmithKline, LLC. ($29.68) |
| 2022 | $269.88 | 15 | Takeda Pharmaceuticals U.S.A., Inc. ($173.17) |
| 2021 | $30.90 | 2 | Takeda Pharmaceuticals U.S.A., Inc. ($30.90) |
| 2020 | $157.05 | 9 | AstraZeneca Pharmaceuticals LP ($31.08) |
| 2019 | $556.49 | 44 | Novo Nordisk Inc ($176.41) |
| 2018 | $609.61 | 45 | Merck Sharp & Dohme Corporation ($106.08) |
| 2017 | $845.33 | 72 | Allergan Inc. ($281.95) |
All Payment Transactions
191 individual payment records from CMS Open Payments — Page 8 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/11/2017 | PFIZER INC. | CHANTIX (Drug), FLECTOR PATCH, LYRICA | Food and Beverage | In-kind items and services | $0.38 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 03/28/2017 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/21/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: DIABETES | ||||||
| 03/15/2017 | GlaxoSmithKline, LLC. | ADVAIR (Drug), FLOVENT | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: RESPIRATORY | ||||||
| 03/07/2017 | Merck Sharp & Dohme Corporation | ZOSTAVAX (Biological), PNEUMOVAX 23, GARDASIL9 | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: VACCINE | ||||||
| 02/28/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/28/2017 | PFIZER INC. | LYRICA (Drug), FLECTOR PATCH, CHANTIX | Food and Beverage | In-kind items and services | $1.18 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 02/14/2017 | PFIZER INC. | CHANTIX (Drug), LYRICA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $3.49 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/14/2017 | PFIZER INC. | LYRICA (Drug), CHANTIX | Food and Beverage | In-kind items and services | $1.08 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 01/31/2017 | Takeda Pharmaceuticals America, Inc. | Uloric (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Gout/Rheumatology | ||||||
| 01/31/2017 | PFIZER INC. | LYRICA (Drug), FLECTOR PATCH | Food and Beverage | In-kind items and services | $0.85 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 01/31/2017 | PFIZER INC. | FLECTOR PATCH (Drug), LYRICA | Food and Beverage | In-kind items and services | $0.72 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 01/31/2017 | PFIZER INC. | LYRICA (Drug), FLECTOR PATCH | Food and Beverage | In-kind items and services | $0.57 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 01/31/2017 | PFIZER INC. | CHANTIX (Drug), FLECTOR PATCH, LYRICA | Food and Beverage | In-kind items and services | $0.25 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/20/2017 | PFIZER INC. | VIAGRA (Drug), LYRICA | Food and Beverage | In-kind items and services | $2.47 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);CARDIOVASCULAR;RESPIRATORY | ||||||
| 01/03/2017 | PFIZER INC. | LYRICA (Drug), FLECTOR PATCH | Food and Beverage | In-kind items and services | $2.15 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 788 | 939 | $242,368 | $81,905 |
| 2022 | 11 | 701 | 879 | $235,697 | $75,757 |
| 2021 | 13 | 689 | 869 | $236,291 | $73,167 |
| 2020 | 13 | 775 | 970 | $186,291 | $57,597 |
Total Patients
2,953
Total Services
3,657
Medicare Billing
$288,426
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 229 | 229 | $71,859 | $28,792 | 40.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 165 | 261 | $81,090 | $21,586 | 26.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 146 | 199 | $43,920 | $10,960 | 25.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 30 | 30 | $19,200 | $8,453 | 44.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 67 | 68 | $7,140 | $4,809 | 67.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 21 | $9,211 | $2,237 | 24.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 71 | 72 | $3,435 | $2,117 | 61.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $4,433 | $1,780 | 40.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 35 | 35 | $1,624 | $1,058 | 65.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 13 | $456.00 | $112.80 | 24.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 203 | 203 | $66,178 | $26,092 | 39.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 167 | 284 | $90,880 | $23,664 | 26.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 120 | 174 | $39,498 | $10,210 | 25.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 14 | 14 | $8,960 | $3,880 | 43.3% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 20 | 25 | $12,850 | $3,703 | 28.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 52 | 52 | $5,460 | $3,564 | 65.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 58 | 60 | $2,460 | $1,723 | 70.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 13 | $5,902 | $1,512 | 25.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 25 | 25 | $1,025 | $724.79 | 70.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 15 | 15 | $1,980 | $582.82 | 29.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 14 | 14 | $504.00 | $101.72 | 20.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 185 | 321 | $102,117 | $26,496 | 25.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 186 | 186 | $60,750 | $24,389 | 40.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 103 | 142 | $31,736 | $8,073 | 25.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 21 | 24 | $10,722 | $3,018 | 28.1% |
About Dr. David Hughes, M.D
Dr. David Hughes, M.D is a Family Medicine healthcare provider based in Oldsmar, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831285543.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Hughes, M.D has received a total of $2,549 in payments from pharmaceutical and medical device companies, with $79.69 received in 2023. These payments were reported across 191 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,520).
As a Medicare-enrolled provider, Hughes has provided services to 2,953 Medicare beneficiaries, totaling 3,657 services with total Medicare billing of $288,426. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Oldsmar, FL
- Active Since 10/04/2006
- Last Updated 03/31/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1831285543
Products in Payments
- TRINTELLIX (Drug) $204.07
- FARXIGA (Drug) $167.54
- JANUVIA (Drug) $140.00
- NAMENDA XR (Drug) $139.42
- LINZESS (Drug) $109.79
- CHANTIX (Drug) $97.82
- INVOKANA (Drug) $91.53
- Tresiba (Drug) $79.40
- Ozempic (Drug) $78.54
- LYRICA (Drug) $73.25
- UBRELVY (Drug) $68.02
- Prolia (Biological) $66.78
- JARDIANCE (Drug) $64.50
- Victoza (Drug) $64.16
- TRULICITY (Drug) $63.18
- VIBERZI (Drug) $52.41
- Uloric (Drug) $51.70
- ZOSTAVAX (Biological) $49.30
- PREVNAR - 13 (Biological) $48.10
- TRADJENTA (Drug) $45.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Oldsmar
Howard Chipman, M.d, M.D
Family Medicine — Payments: $69,441
Family Medicine $69,441
Dr. Danny Fox, M.d, M.D
Family Medicine — Payments: $3,498
Family Medicine $3,498
Dr. Juan Falla, M.d, M.D
Family Medicine — Payments: $3,116
Family Medicine $3,116
Robert Dimasi, D.o, D.O
Family Medicine — Payments: $772.14
Family Medicine $772.14
Annie Thomas, Md, MD
Family Medicine — Payments: $495.26
Family Medicine $495.26
Naxdaris Gonzalez, Md, MD
Family Medicine
Family Medicine